Ascletis Pharma Inc Forecast, price target & analysts
Why the stock moved Beta
Ascletis Pharma Inc Target price 2026 - Analyst rating & recommendation
Ascletis Pharma Inc Classifications & Recommendation
Ascletis Pharma Inc Price Target
| Target Price | HK$22.88 |
| Price | HK$8.97 |
| Potential |
155.06%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Ascletis Pharma Inc 2027 .
The average Ascletis Pharma Inc target price is HK$22.88.
This is
155.06%
register free of charge
HK$32.55
262.88%
register free of charge
HK$14.00
56.06%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend Ascletis Pharma Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ascletis Pharma Inc stock has an average upside potential 2027 of
155.06%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million HK$ | 2.37 | 19.25 |
| 58.00% | 712.09% | |
| EBITDA Margin | -21,175.11% | -2,397.99% |
| 25.20% | 88.68% | |
| Net Margin | -17,762.87% | -2,167.55% |
| 24.31% | 87.80% |
5 Analysts have issued a sales forecast Ascletis Pharma Inc 2026 . The average Ascletis Pharma Inc sales estimate is
This results in the following potential growth metrics:
5 Ascletis Pharma Inc Analysts have issued a net profit forecast 2026. The average Ascletis Pharma Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | -0.43 | -0.42 |
| 22.86% | 2.33% | |
| P/E | negative | |
| EV/Sales | 334.61 |
5 Analysts have issued a Ascletis Pharma Inc forecast for earnings per share. The average Ascletis Pharma Inc EPS is
This results in the following potential growth metrics and future valuations:
Ascletis Pharma Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
